Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors. [electronic resource]
- Hematology (Amsterdam, Netherlands) Mar 2014
- 63-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1607-8454
10.1179/1607845413Y.0000000100 doi
Adolescent Adult Chronic Disease Female Hematopoietic Stem Cell Transplantation--adverse effects Humans Leukemia, Myeloid, Chronic-Phase--drug therapy Male Middle Aged Prognosis Protein Kinase Inhibitors--therapeutic use Retrospective Studies Transplantation Conditioning--adverse effects Transplantation, Homologous Treatment Outcome Young Adult